Dimension Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Dimension Therapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 48% to $11,471,000. Profit margin reached -427%. Total operating expenses were $60,521,000.
Profit Margin
| 2015 | 7.75M | -35.05M | -452.34% |
|---|---|---|---|
| 2016 | 11.47M | -49.00M | -427.17% |
DMTX Income Statement (2015 – 2016)
| 2016 | 2015 | |
|---|---|---|
Revenue | ||
Revenue | 11.47M | 7.75M |
Cost of revenue | 0 | 0 |
Gross profit | 11.47M | 7.75M |
Operating exp. | ||
Research and development | 47.74M | 33.99M |
Selling and marketing | 0 | 0 |
Total operating expenses | 60.52M | 42.71M |
Operating income | -49.05M | -34.96M |
Other income (expenses), net | 49K | -91K |
Income before tax | -49.00M | -35.05M |
Income tax expense | 49K | -91K |
Net income | -49.00M | -35.05M |
Earnings per share | ||
Basic EPS | -1.96 | -1.4 |
Diluted EPS | -1.96 | -4.41 |
| Data source | Data source |